| Financial Year |
March 31 2023 |
| Monetary Funds |
232,025,281.46 |
| Held-for-trading Financial Assets |
966,232,753.43 |
| Notes Receivable |
782,241,156.38 |
| Accounts Receivable |
1,342,562,125.72 |
| Advances to Suppliers |
24,595,759.68 |
| Other Receivables |
27,247,726.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,167,550,120.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,985,646.21 |
| Total Current Assets |
4,612,303,108.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
89,755,443.59 |
| Investment Properties |
53,744,541.07 |
| Fixed Assetes |
572,955,886.19 |
| Under-construction Projects |
252,191,183.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
34,606,401.29 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
40,311,848.44 |
| Deferred Income Tax Assets |
67,587,974.15 |
| Other Non-Current Assets |
88,925,762.30 |
| Sub-Total of Non-Current Assets |
1,210,036,200.91 |
| Total Assets |
5,822,339,309.86 |
| Short-Term Loans |
25,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
115,862,253.23 |
| Accounts Payable |
398,030,569.11 |
| Accounts Received In Advance |
996,666.67 |
| Employee Compensation Payable |
41,667,082.02 |
| Taxes Payable |
75,333,199.65 |
| Interest Payable |
17,222.22 |
| Dividend Payable |
-- |
| Other payables |
3,720,244.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,598,548.28 |
| Other Current Liabilities |
4,196,673.70 |
| Sub-Total of Current Liabilities |
698,687,342.28 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
18,231,646.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
268,125,901.41 |
| Total Liabilities |
966,813,243.69 |
| Paid-In Capital(Or Share Stock) |
411,839,845.00 |
| Capital Surplus |
1,646,429,900.68 |
| Surplus Reserve |
298,537,033.88 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,251,441,496.33 |
| Minority Stockholder's Interest |
247,277,790.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,608,248,275.89 |
| Owner's Equity（Stockholder's Equity） |
4,855,526,066.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,822,339,309.86 |
